Aix-Marseille Université URMITE, UM63, CNRS 7278, IRD 198, INSERM 1095, Marseille, France.
J Clin Microbiol. 2013 Oct;51(10):3286-93. doi: 10.1128/JCM.00473-13. Epub 2013 Jul 24.
Studying the relationships between gut microbiota, human health, and diseases is a major challenge that generates contradictory results. Most studies draw conclusions about the gut repertoire using a single biased metagenomics approach. We analyzed 16 different stool samples collected from healthy subjects who were from different areas, had metabolic disorders, were immunocompromised, or were treated with antibiotics at the time of the stool collection. The analyses performed included Gram staining, flow cytometry, transmission electron microscopy (TEM), quantitative real-time PCR (qPCR) of the Bacteroidetes and Firmicutes phyla, and pyrosequencing of the 16S rRNA gene amplicons targeting the V6 region. We quantified 10(10) prokaryotes per gram of feces, which is less than was previously described. The Mann-Whitney test revealed that Gram-negative proportions of the prokaryotes obtained by Gram staining, TEM, and pyrosequencing differed according to the analysis used, with Gram-negative prokaryotes yielding median percentages of 70.6%, 31.0%, and 16.4%, respectively. A comparison of TEM and pyrosequencing analyses highlighted a difference of 14.6% in the identification of Gram-negative prokaryotes, and a Spearman test showed a tendency toward correlation, albeit not significant, in the Gram-negative/Gram-positive prokaryote ratio (ρ = 0.3282, P = 0.2146). In contrast, when comparing the qPCR and pyrosequencing results, a significant correlation was found for the Bacteroidetes/Firmicutes ratio (ρ = 0.6057, P = 0.0130). Our study showed that the entire diversity of the human gut microbiota remains unknown because different techniques generate extremely different results. We found that to assess the overall composition of bacterial communities, multiple techniques must be combined. The biases that exist for each technique may be useful in exploring the major discrepancies in molecular studies.
研究肠道微生物群、人类健康和疾病之间的关系是一个重大挑战,因为它会产生相互矛盾的结果。大多数研究都是使用单一的有偏差的宏基因组学方法来得出关于肠道菌群的结论。我们分析了 16 份来自不同地区、有代谢紊乱、免疫功能低下或在粪便采集时接受抗生素治疗的健康受试者的粪便样本。分析包括革兰氏染色、流式细胞术、透射电子显微镜(TEM)、厚壁菌门和拟杆菌门的定量实时 PCR(qPCR)以及靶向 V6 区的 16S rRNA 基因扩增子的焦磷酸测序。我们定量了每克粪便中有 10(10)个原核生物,这比以前描述的要少。曼-惠特尼检验显示,通过革兰氏染色、TEM 和焦磷酸测序获得的原核生物革兰氏阴性比例因分析方法而异,革兰氏阴性原核生物的中位数分别为 70.6%、31.0%和 16.4%。TEM 和焦磷酸测序分析的比较突出了革兰氏阴性原核生物鉴定的 14.6%差异,Spearman 检验显示革兰氏阴性/革兰氏阳性原核生物比值存在相关性,尽管不显著(ρ=0.3282,P=0.2146)。相比之下,当比较 qPCR 和焦磷酸测序结果时,发现厚壁菌门/拟杆菌门比值存在显著相关性(ρ=0.6057,P=0.0130)。我们的研究表明,人类肠道微生物群的整个多样性仍然未知,因为不同的技术会产生截然不同的结果。我们发现,为了评估细菌群落的整体组成,必须结合多种技术。每种技术存在的偏差可能有助于探索分子研究中的主要差异。